One of the key factors driving the growth of the malaria vaccines market is the high incidence of malaria in many regions around the world, particularly in sub-Saharan Africa. According to the World Health Organization (WHO), there were an estimated 229 million cases of malaria worldwide in 2019, with 409,000 deaths. Malaria Vaccines Market is a significant public health concern in many countries, and the development of effective vaccines is essential to reduce the burden of the disease. Despite these limitations, RTS,S/AS01 has received a positive opinion from the European Medicines Agency (EMA) for use in children aged 6 weeks to 17 months living in malaria-endemic areas. The vaccine has also been recommended for pilot implementation by the WHO in three African countries, Ghana, Kenya, and Malawi, as part of a larger effort to evaluate the feasibility, impact, and cost-effectiveness of using the vaccine in routine immunization programs.
Read more @ https://influentialblogging.blogspot.com/2023/03/global-malaria-vaccines-market-is.html
